The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer.

ABSTRACT:

Background

Systemic immune-inflammation index (SII) has recently emerged as a biomarker for the prognosis of a variety of malignant tumors. However, the role of SII in bladder cancer (BC) remains unclear. To this end, we performed a pooled analysis to investigate the prognostic value of preoperative SII in patients with BC.

Methods

A comprehensive search of electronic databases (PubMed/Medline, Web of Science, Scopus, and Cochrane Central Register of Controlled Trials) was conducted to determine the eligible studies that were published until January 2022. Pooled hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the association between preoperative SII and the prognosis and clinicopathological characteristics of BC.

R

SUBMITTER: Li J 

PROVIDER: S-EPMC9097688 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature